Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effect of Different Currents for Transcranial Modulation of the Sensorimotor Corticospinal Pathway in Healthy Subjects (CURRENT-Flow)

16 settembre 2026 aggiornato da: Hospital de Clinicas de Porto Alegre

Effect of Different Currents for Transcranial Modulation of the Sensorimotor Corticospinal Pathway in Healthy Subjects: A Randomized Clinical Trial

Transcranial modulation of the corticospinal sensorimotor pathway is a promising approach in neuroscientic functions. Among the techniques used, transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS) and the application of random noise current stand out. Objective: To compare the e stimulus, in the EEG frequency bands, on Motor Evoked Potentials (MEP) and on the functional activation of the motor cortex, assessed by Functional Near Infrared Spectroscopy (fNIRS) and pain measurements in healthy subjects subjected to a standardized algogenic stimulus. Subjects and Method: This is a randomized, double-blind, controlled and crossover clinical trial, involving the inclusion of 14 healthy male subjects, with complete secondary education, aged between 18 and 40. years. Participants will be randomized to receive Transcranial Direct Current Stimulation (tDCS), (2) Transcranial Alternating Current Stimulation (tACs), (3) Random Noise Current, (4) Simulated Stimulation Session and (5) Rest Session. Experimental conditions will take place in a standard, quiet and bright room. Assessments will include Motor Evoked Potential, Heat Pain Threshold, Motor Area Activation through metabolic activation measured by fNIRS and analysis of EEG frequency waves. After the baseline assessment, participants will undergo a session of transcranial stimulation, followed by an algogenic stimulus with water at zero degrees, immersion of the dominant hand for 1 minute, with rest intervals of 3 minutes between each of the four serial stimuli. After this stimulus session, outcome measurements will be carried out. Expected results: This clinical trial is expected to provide insights into how tDCS, tACs and random stimulation in to an algogenic stimulus. The results may contribute to the development of therapeutic or neuromodulation strategies in clinical conditions where the regulation of the cortico-spinal sensorimotor pathway is relevant.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

14

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brasile
        • Hospital de Clinicas de Porto Alegre

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 45 anni (Adulto)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Maschio

Descrizione

Inclusion Criteria:

  • Healthy male subjects aged 18-45 years, with at least a high school diploma, and not engaged in night-shift work.

Exclusion Criteria:

  • Contraindications to transcranial stimulation include implanted medical devices in the brain, cardiac pacemakers, and cochlear implants.
  • Current use of psychotropic medications.
  • History of alcohol or substance abuse within the past 6 months.
  • Neurological disorders, history of traumatic brain injury, or prior neurosurgery.
  • Beck Depression Inventory-II (BDI-II) score >13.
  • Self-Reporting Questionnaire (SRQ) score >7.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Triplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Transcranial Direct Current Stimulation (tDCS) over motor area (M1)

Participants receive active transcranial direct current stimulation over the primary motor cortex (M1) during the intervention sessions.

Stimulation is delivered using two sponge electrodes (5 × 7 cm) mounted on a neoprene cap. The electrodes are positioned on the scalp according to the international 10-20 system. The anode is placed at position C3 (left primary motor cortex, M1) and the cathode over the ipsilateral clavicular region. The sinusoidal current intensity per channel ranges from ±2 mA. The session duration is 20 minutes.

Altri nomi:
  • tDCS
Comparatore attivo: Transcranial Alternating Current Stimulation (tACS) over M1

Participants receive active transcranial alternating current stimulation over the primary motor cortex (M1) during the intervention sessions.

Single session of active gamma transcranial alternating current stimulation delivered for 30 minutes using a battery-powered external stimulator. Stimulation is applied through two sponge electrodes (5 × 7 cm) mounted on a neoprene cap. The stimulation frequency is 40 Hz, based on previous gamma-band transcranial alternating current stimulation (tACS) studies. The anode is positioned at C3 (left primary motor cortex, M1), and the cathode over the ipsilateral clavicular region.

Altri nomi:
  • tACS
Comparatore attivo: Transcranial Random Noise Stimulation (tRNS) over M1

Participants receive active transcranial random noise stimulation over the primary motor cortex (M1) during the intervention sessions.

Stimulation is delivered using two sponge electrodes mounted on a neoprene cap. The anode is positioned at C3 (left primary motor cortex, M1), and the cathode over the ipsilateral clavicular region. A random current level is generated for each sample at a sampling rate of 1280 samples per second. The random values are normally distributed, following a bell-shaped probability density function. The noise signal contains all frequencies up to half the sampling rate (maximum 640 Hz) and has no DC offset.

Altri nomi:
  • tRNS
Comparatore fittizio: Sham Stimulation

Participants undergo sham stimulation, experiencing the same setup as active stimulation without actual current delivery.

During the sham stimulation session, the tDCS device ramps up the current to 2 mA over 30 seconds and then is immediately turned off. This procedure mimics the sensations of active stimulation without delivering therapeutic current for the remainder of the session.

Altri nomi:
  • finto
Nessun intervento: Rest State

Participants remain seated with their eyes open for 20 minutes during the rest session, without performing any other task.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Resting-State EEG Power Spectra Across Frequency Bands (Delta, Theta, Alpha, Beta 1, Beta 2, and Gamma)
Lasso di tempo: Immediately before and immediately after the intervention.

Electroencephalography (EEG) will be used to quantify neuronal activity through quantitative EEG (qEEG) analysis. Resting-state EEG power spectra will be analyzed across delta, theta, alpha, beta, and gamma frequency bands, reflecting synchronized neuronal oscillations. EEG data will be recorded using a 20-electrode montage according to the international 10-20 system during an 8-minute resting-state paradigm with alternating eyes-open and eyes-closed conditions. Cortical source localization will be performed using standardized Low-Resolution Brain Electromagnetic Tomography (sLORETA).

Immediately before and immediately after the intervention.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Corticospinal Excitability
Lasso di tempo: Immediately before and immediately after the intervention.

Corticospinal excitability will be assessed using single-pulse transcranial magnetic stimulation (TMS) applied over the left primary motor cortex. Motor evoked potentials (MEPs) will be recorded from the right first dorsal interosseous muscle, and measures will include resting motor threshold (RMT) and MEP amplitude, with MEPs obtained at 130% of the motor threshold.

Immediately before and immediately after the intervention.
Motor Cortex Functional Connectivity
Lasso di tempo: Immediately before and immediately after the intervention.

Functional connectivity of the motor cortex will be assessed using functional near-infrared spectroscopy (fNIRS) with a continuous-wave NirScout® system. Optodes will be positioned according to the international 10-10 system to cover the bilateral motor cortex. Data will be acquired during resting-state conditions and during the cold pressor task. Functional connectivity will be analyzed within predefined motor cortex regions of interest.

Immediately before and immediately after the intervention.
Heat Pain Threshold
Lasso di tempo: Immediately before and immediately after the intervention.

Heat pain threshold will be assessed via quantitative sensory testing (QST) on the left forearm using a thermode that increases temperature from 30°C to 52°C at a rate of 1°C per second. The pain threshold is calculated as the average temperature at which pain is first reported across three trials. Higher values indicate greater pain threshold.

Immediately before and immediately after the intervention.
Function of the Descending Pain Inhibitory System
Lasso di tempo: Immediately before and immediately after the intervention.

The function of the descending pain inhibitory system will be assessed using the Conditioned Pain Modulation Test (CPM-test). Pain intensity is rated using a verbal numerical rating scale (0 = no pain to 10 = worst possible pain) before (T0) and during (T1) cold-water immersion. The CPM effect is calculated as the difference between pain ratings at T0 and T1, with greater reductions indicating more effective pain inhibition.

Immediately before and immediately after the intervention.
Cold Pressor Test Pain Tolerance
Lasso di tempo: Immediately before and immediately after the intervention.

Pain intensity and tolerance will be assessed using the Cold Pressor Test, in which participants immerse the non-dominant hand in ice-saturated water (~1°C) for up to 2 minutes. Pain intensity will be continuously rated using an electronic visual analog scale, allowing calculation of peak pain, mean pain, and area under the curve (AUC) over the test duration.

Immediately before and immediately after the intervention.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 luglio 2026

Completamento primario (Stimato)

26 ottobre 2026

Completamento dello studio (Stimato)

26 dicembre 2026

Date di iscrizione allo studio

Primo inviato

13 gennaio 2026

Primo inviato che soddisfa i criteri di controllo qualità

16 settembre 2026

Primo Inserito (Effettivo)

21 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

21 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

16 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Altri numeri di identificazione dello studio

  • 81182524.7.0000.5327
  • 20240121 (Altro identificatore: HCPA)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

Data will be available upon request at wcaumo@hcpa.edu.br after 6 months of publication.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi